湖北是科教大省，是首批国家创新型省份，在国家创新体系布局中处于重要位置。近年来，湖北省委、 省政府牢记"努力打造具有全国影响力的科技创新高地"的殷殷嘱托，深入实施创新驱动发展战略：基础 研究基石不断夯实，关键技术不断取得突破，科技创新和产业创新"双向奔赴"……在全国科技创新版图 上，成功迈入"第一方阵"。 增动能 2021年4月12日，《湖北省国民经济和社会发展第十四个五年规划和二〇三五年远景目标纲要》正式发 布，专章部署"坚持创新第一动力，增强发展新动能"，把创新摆在事关发展全局的核心位置。 根据纲要，在推动关键核心技术攻关方面，实施关键核心技术攻关工程，湖北将围绕三维存储芯片、硅 光芯片、新型显示材料、高端医学影像设备等重点领域，加强产业链上下游协同，推动"临门一脚"关键 技术产业化，实现率先突破。 在创新平台建设工程方面，湖北聚焦光电科学、先进存储、生物安全、空天信息、生命健康、智能制 造、长江生态、现代农业、生物育种等优势特色领域，加快推进光谷实验室、珞珈实验室、江夏实验 室、洪山实验室、九峰山实验室等建设。 同时，湖北着力培育具有国际竞争力的万亿元级光电子信息、大健康产业集群。发挥"光芯屏端网"等重 ...

近期，广东、海南等地保险业积极应对今年第1号台风"蝴蝶"影响，加快海洋牧场赔案处理进度，全力 支持受灾养殖户渡过难关。 针对海洋牧场风险高、监测难的问题，人保财险采取"保险+风险减量服务+科技"模式，引入GIS地理信 息系统、大数据分析等新技术手段，实现远程水质水温监测、预警提醒、自动控制、PH传感监测、溶 解氧及气象综合数据的实时变化波动等功能，同时对场景周围环境实现实时远程视频监控，大幅提升了 防灾减损效率。 为破解海洋牧场投资成本高、融资难融资贵的问题，中国人寿财险公司充分发挥保险风险管理与增信融 资作用，联合中国人寿集团成员单位广发银行，优化完善"保险+信贷"综合服务模式，通过保单质押、 保险增信等方式，为海洋牧场经营者提供贷款授信服务。其中，2024年为山东财金万泽丰海洋科技公司 的深远海三文鱼养殖项目定制专属服务方案，为养殖设施提供"一揽子"风险保障8573万元，帮助该企业 获得贷款授信额度5000万元。 "保障渔民生计，是我们服务乡村全面振兴、支持海洋经济高质量发展的责任所在。"人保财险有关负责 人表示，公司统筹防灾减灾和快速理赔资源，通过科技赋能实现精准预警、快速响应。未来，保险业将 以更智能 ...

6月25日，肇庆高新区召开土地推介会，重点推出27宗、约1110亩优质地块，旨在通过高效集约的土地资源配置，满足产业蓬勃发展催生的多层次居住需求 与消费需求，为区域产业转型升级注入强劲动能。 Teleco th 78 e 78 d a ( 0 � e ● 0 0 0 C e e 0 (8) 32 0 0 17 0 0 6 03 0 0 (0) (3) 0 0 0 ® 0 0 0 0 ® 0 0 0 0 0 e 0 0 0 0000000 0 0 0 6 0 s Pr O 15 000000000 0 O 0 00 00000 0 00000000 Q 0 0 0 0 0 0 0 00000 0 10 0 0 c 0 o 0000000 D 00 0 0 0 0 0000 27 0 o o 0 00 Q 000000000 0 0000 0 00000000 o 00 00 000000 0 00000 0 0 00000 0 0 o 0 0 o e 01 000000 0 0 0 o e 0 000 6 e 0 e 0 00000 0 0 o 4 000 0 0 B 0 0 e 0 0 0 0 0 0 0 0 ...

Core Viewpoint - Appili Therapeutics has successfully re-launched LIKMEZ™ (ATI-1501), a metronidazole oral suspension, and is actively pursuing funding opportunities to support its development programs and enhance its market position [2][3][14]. Group 1: Product Development and Market Position - LIKMEZ™ (ATI-1501) is the first FDA-approved, ready-to-use liquid oral suspension of metronidazole, specifically designed for patients who have difficulty swallowing tablets or are sensitive to taste [3][4]. - The re-launch of LIKMEZ follows new patent coverage extending to 2039, marking a significant milestone for the company and its partner, Saptalis Pharmaceuticals [2]. - Appili is focused on driving continued sales of LIKMEZ while advancing other product candidates, including ATI-1701 and ATI-1801 [3]. Group 2: Funding and Financial Performance - The company has submitted five non-dilutive funding proposals to the U.S. government, with a total potential value of up to US$125 million, aimed at supporting the development of critical infectious disease products [3][14]. - For the fiscal year ended March 31, 2025, Appili reported a net loss of CAD 2.6 million, which is an improvement from a net loss of CAD 3.8 million in the previous year, primarily due to increased government assistance and other income [19][20]. - As of March 31, 2025, the company had cash reserves of CAD 1.2 million, a significant increase from CAD 0.1 million a year earlier, indicating improved liquidity [21]. Group 3: Research and Development Progress - ATI-1701, a biodefense vaccine candidate for tularemia, has received approximately US$11.6 million in funding from the U.S. Air Force Academy and has shown promising results in providing protection against lethal tularemia [5][6]. - The company is actively pursuing additional funding and partnership opportunities for ATI-1801, a topical antiparasitic product that has received Orphan Drug Designation from the FDA [10][13]. - Appili has successfully completed technology transfer for the ATI-1701 manufacturing process, supporting future development activities [8].

黄海岸边，巨轮穿梭，桥吊林立。作为北方第一大港、全球第五大集装箱港，山东港口青岛港深度赋能 国际航运中心建设，书写经略海洋、向海图强的新篇章。从战略蓝图到硬核突破，从数智革命到绿色转 型，这座百年大港正以创新为翼、以开放为帆，在全球航运版图中勾勒出"青岛坐标"。 建设青岛国际航运中心，不仅是服务和融入新发展格局、黄河流域生态保护和高质量发展等重大国家战 略的重要支撑，也是在山东打造世界级海洋港口群中"打头阵、当先锋"的必然要求，更是青岛港做 到"三个更加、三个满意"、助力地方经济高质量发展的关键举措。山东港口青岛港党委书记、董事长苏 建光在2025年4月17日的青岛国际航运中心建设工作推进会上直言，"我们正以'三个必须'(必须反应快、 必须抓提前、必须质量高)的劲头，将'规划图'变成'施工图'，把'时间表'变成'计程表'。" 记者 赵波 青岛报道 顶格推进： 从战略蓝图到专班攻坚的机制创新 硬核突破： 从码头集群到航线网络的能级跃升 通过董家口调度指挥中心的大屏幕清晰地看到，远处的青岛港董家口港区第二座40万吨级矿石码头正在 如火如荼地建设中——这里正建设青岛港"十四五"期间最大的专业化码头集群项目之一。"建 ...

目前，国家医保服务平台已开放医保药品耗材追溯信息查询功能，所有药店均可使用该功能对购进的药 品进行扫码查验。"出现扫码异常时建议拒绝收货，记录交易时间、地点、人员特征，保存聊天记录、 药品照片、转账凭证等证据，并向有关部门举报。"国家医保局有关负责人表示，根据相关法律法规， 收售"回流药"将面临罚款、行政处罚等处置措施。 现阶段，"买药先验码、卖药必扫码"的社会共识已经基本形成，每天约有500万人次消费者通过药品追 溯码查验药品真伪并主动维权。国家医保局相关负责人表示，将持续加强运用药品追溯码开展监管的力 度，联合有关部门对倒卖"回流药"开展全链条、各环节的严厉打击，通过一案多查、联合惩戒，推动实 现倒卖"回流药"全域治理，确保人民群众用药安全，守牢医保基金安全底线。 （文章来源：经济日报） 自2024年国家医保局在全国范围推进药品追溯码采集应用工作以来，数据壁垒被打破，药品追溯体系建 设延伸到医院、药店和参保人等终端使用群体。截至目前，已累计归集药品追溯码398.85亿条，助力打 击药品领域"回流药"问题。 药品追溯码就是每盒药品的"电子身份证"，具有唯一性。一盒药品的追溯码，只应有一次被扫码销售的 记录， ...

为直观验证，记者跟随检测人员来到位于武汉武昌核心区的220千伏体育馆变电站。在变电站内设备区 和紧邻公众区域的围墙边，工程师架设了专业仪器进行多点检测。实测结果显示：变电站围墙附近的电 场强度在2.15伏/米至2.20伏/米之间，磁感应强度则在0.23微特至0.30微特之间波动。 "房子不能挨着变电站，辐射大""变电站辐射会致癌"……类似这样的担忧在生活中并不少见。变电站作 为保障城市运转的电力枢纽，为何总与"辐射"传言相伴？它真的如人们担心的那样可怕吗？ 近日，记者带着疑问走访了有关专家，并深入武汉城市中心一座变电站进行实地检测。 核工业二七〇研究所工程师周亚飞首先澄清了一个关键概念。"公众常将变电站、高压线乃至家电周围 的'工频电磁场'误认为有害的'电磁辐射'，这是一个误区。"周亚飞解释道，真正需要警惕的辐射，是像 X光、手机信号那样能在空间传播的电磁波。而变电站产生的，是频率仅为50赫兹的工频电场和磁场。 它们更像是一种紧贴着设备、随距离快速衰减的"场"，本质上不具备有效辐射出去的能量。 那么，这种"场"是否安全？周亚飞表示，关键在于其强度是否在安全限值内。我国对居民区工频电磁场 的推荐标准为：电场强度 ...

Financial Data and Key Metrics Changes - The company reported the election of two class one directors, John W. Thompson and Yvonne Lassner, during the annual meeting [11] - KPMG LLP was ratified as the independent registered public accounting firm for the fiscal year ending January 31, 2026 [11] Business Line Data and Key Metrics Changes - No specific business line data or key metrics were discussed in the meeting [9] Market Data and Key Metrics Changes - No specific market data or key metrics were provided during the meeting [9] Company Strategy and Development Direction and Industry Competition - The meeting focused on the election of directors and the appointment of auditors, with no detailed discussion on company strategy or industry competition [7][11] Management's Comments on Operating Environment and Future Outlook - Management did not provide comments on the operating environment or future outlook during the meeting [9] Other Important Information - The meeting was conducted virtually, and the rules of conduct were established to ensure an orderly process [4][5] - The preliminary voting results will be reported in a timely manner, with final results expected to be filed within four business days after the meeting [11][12] Q&A Session Summary Question: Were there any questions submitted during the meeting? - There were no questions submitted during the meeting [9]

Financial Data and Key Metrics Changes - In Q4 2025, the company generated adjusted earnings of $0.60 per share, significantly outperforming guidance, with consolidated net sales of $962 million, up 8.2% year over year [22][23] - Consolidated backlog increased by $78 million to $761 million, driven by improved demand [23] - Consolidated gross margin was 39.2%, slightly down from last year but up 130 basis points sequentially [23][24] Business Line Data and Key Metrics Changes - North America contract segment net sales were $496 million, up nearly 13% year over year, with new orders at $568 million, reflecting growth of almost 16% [25] - International contract segment net sales improved to $186 million, up 6.9% year over year, with new orders at $190 million, a 3.6% increase [26] - Global retail segment net sales were $280 million, up 2.2% on a reported basis, with new orders improving to $280 million, up 7.5% [27][28] Market Data and Key Metrics Changes - The company noted a return to order growth in the North American contract segment in Q4 after a dip due to tariffs [15][16] - Strength was observed in European and UK markets, with significant customer engagement during design events [17] - Office leasing activity is rising, with a 68% increase in days in the office among Fortune 100 companies since 2022 [18] Company Strategy and Development Direction - The company is focused on expanding its retail footprint, planning to open 10 to 15 new stores in fiscal 2026 [12][13] - Investment in product assortment expansion and e-commerce penetration is a priority to drive revenue growth [13][14] - The company aims to balance long-term growth with prudent cost management and innovation [20] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about the macroeconomic environment, noting a dynamic landscape with potential for growth in contract markets [15][19] - The company anticipates that pricing actions will offset tariff-related cost impacts in the latter half of fiscal 2026 [30][31] - Management highlighted strong internal indicators for growth, including increased customer activity and order trends [19][57] Other Important Information - The company paid approximately $52 million in dividends and returned about $85 million to shareholders through share repurchases in fiscal 2025 [29] - Capital expenditures for fiscal 2025 were $107.6 million, with expectations to increase to between $120 million and $130 million in fiscal 2026 [29] Q&A Session Summary Question: Insights on pull forward effect from pricing actions - Management noted a mid-single-digit decline in order entry year over year in early Q1, aligning with expectations due to pull forward [35][37] Question: Confidence in retail store openings amid softer demand - Management expressed confidence in retail expansion, citing a need in the market and a strategy to open stores prudently [38][39] Question: Clarification on North American pull forward estimates - Management confirmed an estimated pull forward of $55 million to $60 million, with significant orders expected in Q1 and Q2 [51][59] Question: Profitability impact from pull forward and tariffs - Management indicated that the impact from pull forward would be most significant in Q1, with a gradual decrease in Q2 [58][59] Question: Balance sheet and cash flow considerations - Management highlighted a focus on managing debt levels while increasing capital expenditures for store openings [61]

高新技术企业的奖补资金、专精特新"小巨人"企业的奖补资金、科技创新贷款的实施……"十四五"期 间，政策扶持像及时雨，为我们带来了数百万元的资金支持。经科技部门帮助，我们与三峡大学达成合 作，共建省级企校联合创新中心。 我是在锻造车间摸爬滚打了十几年的"老匠人"。5年前，新能源汽车蓬勃发展，公司因燃油车市场变化 开始出现亏损，赖以生存的发动机连杆滞销。那阵子，公司总经理王长宏和我们看着下跌的订单数，心 里都十分着急。 也是在那一年，宜都大力支持企业科技创新，进企业向我们宣传了新出台的政策。公司终于下定决心： 转型！搞球颈接臂！ 球颈接臂主要用于高端车的隐形牵引，技术含量和生产工艺难度更高，是后拖车系统的关键零部件之 一。我主动请缨，开展技术研发。 创新转型，谈何容易？与传统连杆产品的对称结构相比，球颈接臂为异形结构，模具设计、加工工艺、 锻造定位点等都要重来。我和团队攻坚了3个月，才熬出来一个初版模具。模具试制那天，球颈接臂的 异形结构使新模具的寿命只有其他产品的六分之一。我们只能返工，历经数十次试验，终于生产出了合 格的产品。由于订单少，产品很长时间没有盈利。但我们坚信："创新是大势所趋，不能半途而废。" 落 ...